Skip to content
Home
Team
Therapies
Overview/Pipeline
IC/BPS
Alenura™
Investor
News
Contact Us
Investor Login
Category: Investor News
Vaneltix enters joint development agreement with Hyloris Pharmaceuticals
December 21, 2021
On Thursday, December 16, Vaneltix entered into a Joint Development Agreement with Hyloris Pharmaceuticals NV, a Belgian pharmaceuticals company (“Hyloris”)…
Read More
Closing of shareholder offering
November 25, 2020
Vaneltix announces the results of the 2020 Stockholder Offering and Bridge Loan Conversion: The company raised additional proceeds of $900,000…
Read More